Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Hongyan Li, Christoph Engel, Miguel de la Hoya, Paolo Peterlongo, Drakoulis Yannoukakos, Luca Livraghi, Paolo Radice, Mads Thomassen, Thomas van Overeem Hansen, Anne‐Marie Gerdes, Henriette Roed Nielsen, Sandrine M. Caputo, Alberto Zambelli, Åke Borg, Ángela R. Solano, Abigail Thomas, Michael T. Parsons, Antonis C. Antoniou, Goska Leslie, Xin Yang, Georgia Chenevix‐Trench, Trinidad Caldés, Ava Kwong, Inge Søkilde Pedersen, Charlotte Kvist Lautrup, Esther M. John, Mary Beth Terry, John L. Hopper, Melissa C. Southey, Irene L. Andrulis, Marc Tischkowitz, Ramūnas Janavičius, Susanne E. Boonen, Lone Kroeldrup, Liliana Varesco, Ute Hamann, Ana Vega, Edenir Inêz Palmero, Judy E. Garber, Marco Montagna, Christi J. van Asperen, Lenka Foretová, Mark H. Greene, Tina Selkirk, Pål Møller, Amanda E. Toland, Susan M. Domchek, Paul A. James, Heather Thorne, Diana M. Eccles, Sarah M. Nielsen, Siranoush Manoukian, Barbara Pasini, Maria A. Caligo, Conxi Lázaro, Judy Kirk, Barbara Wappenschmidt, Amanda B. Spurdle, Fergus J. Couch, Rita K. Schmutzler, David E. Goldgar